World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
64
Citations
14331
World Ranking
2617
National Ranking
1053

Yvonne J. Bryson publication distribution in Microbiology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Microbiology in 2026. The highlighted bar marks where Yvonne J. Bryson sits on this spectrum.

55–64 publications: 8 scientists 65–74 publications: 29 scientists 75–84 publications: 55 scientists 85–94 publications: 112 scientists 95–104 publications: 137 scientists 105–114 publications: 190 scientists 115–124 publications: 235 scientists 125–134 publications: 234 scientists 135–144 publications: 288 scientists 145–154 publications: 264 scientists 155–164 publications: 264 scientists 165–174 publications: 253 scientists 175–184 publications: 276 scientists 185–194 publications: 190 scientists 195–204 publications: 233 scientists 205–214 publications: 207 scientists 215–224 publications: 198 scientists 225–234 publications: 155 scientists 235–244 publications: 161 scientists 245–254 publications: 160 scientists 255–264 publications: 146 scientists 265–274 publications: 139 scientists 275–284 publications: 148 scientists 285–294 publications: 115 scientists 295–304 publications: 96 scientists 305–314 publications: 88 scientists 315–324 publications: 106 scientists 325–334 publications: 65 scientists 335–344 publications: 76 scientists 345–354 publications: 64 scientists 355–364 publications: 62 scientists 365–374 publications: 65 scientists 375–384 publications: 61 scientists 385–394 publications: 34 scientists 395–404 publications: 44 scientists 405–414 publications: 36 scientists 415–424 publications: 35 scientists 425–434 publications: 29 scientists 435–444 publications: 33 scientists 445–454 publications: 34 scientists 455–464 publications: 25 scientists 465–474 publications: 26 scientists 475–484 publications: 20 scientists 485–494 publications: 19 scientists 495–504 publications: 16 scientists 505–514 publications: 17 scientists 515–524 publications: 23 scientists 525–534 publications: 14 scientists 535–544 publications: 14 scientists 545–554 publications: 18 scientists 555–564 publications: 12 scientists 565–574 publications: 7 scientists 575–584 publications: 9 scientists 585–594 publications: 9 scientists 595–604 publications: 9 scientists 605–614 publications: 7 scientists 615–624 publications: 9 scientists 625–634 publications: 7 scientists 635–644 publications: 4 scientists 645–654 publications: 5 scientists 655–664 publications: 6 scientists 665–674 publications: 7 scientists 675–678 publications: 3 scientists 679+ publications: 99 scientists
55 publications 679+

This scientist: 180 publications — 41st percentile

41% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 679 publications or more.

Yvonne J. Bryson D-index placement in Microbiology in 2026

The chart shows the D-index (discipline H-index) distribution of Microbiology scientists ranked by Research.com in 2026. The highlighted bar marks where Yvonne J. Bryson sits on this spectrum.

40 D-Index: 30 scientists 41 D-Index: 86 scientists 42 D-Index: 90 scientists 43 D-Index: 117 scientists 44 D-Index: 122 scientists 45 D-Index: 123 scientists 46 D-Index: 108 scientists 47 D-Index: 110 scientists 48 D-Index: 106 scientists 49 D-Index: 109 scientists 50 D-Index: 129 scientists 51 D-Index: 111 scientists 52 D-Index: 116 scientists 53 D-Index: 127 scientists 54 D-Index: 134 scientists 55 D-Index: 134 scientists 56 D-Index: 111 scientists 57 D-Index: 136 scientists 58 D-Index: 162 scientists 59 D-Index: 151 scientists 60 D-Index: 139 scientists 61 D-Index: 122 scientists 62 D-Index: 126 scientists 63 D-Index: 144 scientists 64 D-Index: 109 scientists 65 D-Index: 103 scientists 66 D-Index: 124 scientists 67 D-Index: 112 scientists 68 D-Index: 103 scientists 69 D-Index: 131 scientists 70 D-Index: 93 scientists 71 D-Index: 93 scientists 72 D-Index: 96 scientists 73 D-Index: 92 scientists 74 D-Index: 80 scientists 75 D-Index: 66 scientists 76 D-Index: 87 scientists 77 D-Index: 60 scientists 78 D-Index: 73 scientists 79 D-Index: 59 scientists 80 D-Index: 57 scientists 81 D-Index: 55 scientists 82 D-Index: 47 scientists 83 D-Index: 77 scientists 84 D-Index: 50 scientists 85 D-Index: 45 scientists 86 D-Index: 42 scientists 87 D-Index: 41 scientists 88 D-Index: 32 scientists 89 D-Index: 38 scientists 90 D-Index: 35 scientists 91 D-Index: 34 scientists 92 D-Index: 27 scientists 93 D-Index: 26 scientists 94 D-Index: 33 scientists 95 D-Index: 22 scientists 96 D-Index: 37 scientists 97 D-Index: 22 scientists 98 D-Index: 21 scientists 99 D-Index: 22 scientists 100 D-Index: 30 scientists 101 D-Index: 16 scientists 102 D-Index: 20 scientists 103 D-Index: 17 scientists 104 D-Index: 19 scientists 105 D-Index: 16 scientists 106 D-Index: 19 scientists 107 D-Index: 18 scientists 108 D-Index: 14 scientists 109 D-Index: 10 scientists 110 D-Index: 9 scientists 111 D-Index: 7 scientists 112 D-Index: 11 scientists 113 D-Index: 6 scientists 114 D-Index: 15 scientists 115 D-Index: 10 scientists 116 D-Index: 12 scientists 117 D-Index: 7 scientists 118 D-Index: 10 scientists 119 D-Index: 10 scientists 120 D-Index: 11 scientists 121 D-Index: 2 scientists 122 D-Index: 7 scientists 123 D-Index: 12 scientists 124 D-Index: 5 scientists 125 D-Index: 9 scientists 126 D-Index: 6 scientists 127+ D-Index: 95 scientists
40 D-Index 127+

This scientist: 64 D-Index — 54th percentile

54% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 127 D-Index or more.

Overview

Yvonne J. Bryson is affiliated with the University of California, Los Angeles in the United States. Their research primarily spans the fields of medicine and immunology and microbiology, with a focus on infectious diseases, immunology, general health professions, epidemiology, and virology.

The scientist's work commonly addresses topics such as HIV/AIDS research and interventions, HIV research and treatment, reproductive system and pregnancy, adolescent sexual and reproductive health, neonatal respiratory health research, immune responses and vaccinations, and HIV/AIDS drug development and treatment.

Frequent venues for their publications include The Lancet HIV, JAIDS Journal of Acquired Immune Deficiency Syndromes, SSRN Electronic Journal, AIDS and Behavior, and Cell Reports Medicine.

Some recent papers by Yvonne J. Bryson include:

  • The systemic inflammatory landscape of COVID-19 in pregnancy: Extensive serum proteomic profiling of mother-infant dyads with in utero SARS-CoV-2, 2021, Cell Reports Medicine
  • Single-Cell Mapping of Progressive Fetal-to-Adult Transition in Human Naive T Cells, 2021, Cell Reports
  • Raltegravir (RAL) in Neonates: Dosing, Pharmacokinetics (PK), and Safety in HIV-1-Exposed Neonates at Risk of Infection (IMPAACT P1110), 2020, JAIDS Journal of Acquired Immune Deficiency Syndromes
  • Optimal strategies to improve uptake of and adherence to HIV prevention among young people at risk for HIV acquisition in the USA (ATN 149): a randomised, controlled, factorial trial, 2024, The Lancet Digital Health
  • Pharmacokinetics and safety of early nevirapine-based antiretroviral therapy for neonates at high risk for perinatal HIV infection: a phase 1/2 proof of concept study, 2020, The Lancet HIV

Yvonne J. Bryson has collaborated extensively with other researchers. Frequent co-authors include Tara Kerin, Ruth Cortado, Stephen A. Spector, Dallas Swendeman, and Manuel A. Ocasio.

Best Publications

  • Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

    Dennis R. Burton;Jayashree Pyati;Raju Koduri;Stephen J. Sharp

  • The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1--a meta-analysis of 15 prospective cohort studies.

    W. Andiman;M. Boucher;D. Burns;Y. Bryson

  • Antiretroviral therapy during pregnancy and the risk of an adverse outcome

    Ruth E. Tuomala;David E. Shapiro;Lynne M. Mofenson;Yvonne Bryson

  • Proposed definitions for in utero versus intrapartum transmission of HIV-1.

    Y J Bryson;K Luzuriaga;J L Sullivan;D W Wara

  • Treatment of first episodes of genital herpes simplex virus infection with oral acyclovir. A randomized double-blind controlled trial in normal subjects.

    Y J Bryson;M Dillon;M Lovett;G Acuna

  • Treatment of Recurrent Genital Herpes Simplex Infections With Oral Acyclovir: A Controlled Trial

    R C Reichman;G J Badger;G J Mertz;L Corey

  • Prolonged Zidovudine Therapy in Patients With AIDS and Advanced AIDS-Related Complex

    Margaret A. Fischl;Douglas D. Richman;Dennis M. Causey;Michael H. Grieco

  • Combination treatment with zidovudine, didanosine, and nevirapine in infants with human immunodeficiency virus type 1 infection

    Katherine Luzuriaga;Yvonne J. Bryson;Paul A. Krogstad;James E. Robinson

  • Three Postpartum Antiretroviral Regimens to Prevent Intrapartum HIV Infection

    Karin Nielsen-Saines;D. Heather Watts;Valdilea G. Veloso;Yvonne J. Bryson

  • Early Treatment with Acyclovir for Varicella Pneumonia in Otherwise Healthy Adults: Retrospective Controlled Study and Review

    David A. Haake;Phillip C. Zakowski;Deborah L. Haake;Yvonne J. Bryson

  • Clearance of HIV Infection in a Perinatally Infected Infant

    Yvonne J. Bryson;Shen Pang;Lian S. Wei;Ruth Dickover

  • Interferon: Immunobiology and Clinical Significance

    E. Richard Stiehm;Lee H. Kronenberg;Howard M. Rosenblatt;Yvonne Bryson

  • Human immunodeficiency virus type 1 genetic evolution in children with different rates of development of disease.

    Shanthi Ganeshan;Ruth E. Dickover;Bette T M Korber;Yvonne J. Bryson

  • Treatment of cytomegalovirus retinopathy with ganciclovir.

    Gary N. Holland;Gary N. Holland;Yossi Sidikaro;Yossi Sidikaro;Allan E. Kreiger;Allan E. Kreiger;David Hardy

  • Deficiency of immune interferon production by leukocytes of normal newborns

    Yvonne J. Bryson;Harland S. Winter;Sherrie E. Gard;Thomas J. Fischer

  • The pharmacokinetics and safety of zidovudine in the third trimester of pregnancy for women infected with human immunodeficiency virus and their infants: Phase I Acquired Immunodeficiency Syndrome Clinical Trials Group study (protocol 082)

    Mary J. O'Sullivan;Pamela J.J. Boyer;Gwendolyn B. Scott;Wade P. Parks

  • Factors predictive of maternal-fetal transmission of HIV-1-preliminary analysis of zidovudine given during pregnancy and/or delivery

    Pamela J. Boyer;Maryanne Dillon;Maryam Navaie;Audra Deveikis

  • Impaired production of gamma-interferon by newborn cells in vitro is due to a functionally immature macrophage.

    Unknown

  • Administration of oral acyclovir suppressive therapy after neonatal herpes simplex virus disease limited to the skin, eyes and mouth: results of a Phase I/ii trial

    David Kimberlin;Dwight Powell;William Gruber;Pamela Diaz

  • Prevention of ultraviolet-light-induced herpes labialis by sunscreen.

    J.F. Rooney;M.L. Mannix;C.R. Wohlenberg;C.J. Wallington

  • Treatment of First Episodes of Genital Herpes Simplex Virus Infection with Oral Acyclovir: A Randomized Double-blind Controlled Trial in Normal Subjects

    Yvonne J. Bryson;Maryanne Dillon;Michael Lovett;Guillermo Acuna

Frequent Co-Authors

Lynne M. Mofenson
Lynne M. Mofenson Elizabeth Glaser Pediatric AIDS Foundation
Diane W. Wara
Diane W. Wara University of California, San Francisco
James D. Cherry
James D. Cherry University of California, Los Angeles
Stephen A. Spector
Stephen A. Spector University of California, San Diego
Beatriz Grinsztejn
Beatriz Grinsztejn Oswaldo Cruz Foundation
E. Richard Stiehm
E. Richard Stiehm University of California, Los Angeles
Katherine Luzuriaga
Katherine Luzuriaga University of Massachusetts Chan Medical School
Lisa M. Frenkel
Lisa M. Frenkel University of Washington
Edward P. Acosta
Edward P. Acosta University of Alabama at Birmingham
Andrea Kovacs
Andrea Kovacs University of Southern California

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring related online degrees can complement your microbiology studies and expand your career opportunities. For those interested in healthcare administration, an medical billing and coding certificate online accelerated offers a fast track to entering the medical records and billing field. This pathway demands attention to detail and can provide a stable career in the health services sector.

If you want to advance clinically while maintaining flexibility, exploring what medical degrees can i get online is essential. Many medical professions now offer programs fully or partially online, allowing for continued education alongside work or research commitments.

Public health is another complementary field. Numerous reputable online MPH programs easy to get into make it accessible to students from diverse academic backgrounds. These degrees equip graduates with skills in epidemiology, policy, and community health, all crucial in microbiology-related public health roles.

For those passionate about working directly with children and families, considering a career as a child life specialists salary offers both fulfillment and competitive compensation. This role involves supporting children's coping mechanisms in medical environments, often intersecting with microbiological healthcare settings.

Best Scientists Citing Yvonne J. Bryson

Trending Scientists